Company / Net Income
Valion Bio, Inc. Net Income History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$8.2M
FY2024
5-year range
-$10.1M / -$8.2M
FY2022-FY2024
Trend
+18.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$8M to -$8M over the past 2 years.
Based on SEC 10-K filings.
-$8M in FY2024.
Improved from -$8M to -$8M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, net income increased 18.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$8.2M | +18.3% |
| FY2023 | -$10.1M | -18.9% |
| FY2022 | -$8.5M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026